The CorMicA (Coronary Microvascular Angina) trial revealed that patients may benefit when coronary microvascular dysfunction (CMD) is accurately diagnosed and appropriately treated.1 Learn more about diagnosing and treating CMD.
RFR clinical evidence derives from assessing over 3,500 lesions in 2,000 patients, and much of that evidence is from ILUMIEN I + PREDICT, VALIDATE RFR, IRIS-FFR and RE-VALIDATE RFR.2-6
Fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) is supported by more than 600 published studies including the FAME clinical trials.7-9
When integrated into cardiac cath lab procedures, measurement of FFR has been shown to reduce the incidence of major adverse coronary events (MACE) in patients being treated for complex coronary artery disease.7
The FAME study—evaluating complex lesions—examined FFR measured exclusively by the PressureWire™ X Guidewire. Results showed that compared to angiography alone, FFR:
Precise measurement of intravascular diagnostics relies on the market-leading PressureWire™ X Guidewire that combines excellent maneuverability—even in tortuous vessels—and reliable readings11, all of which can ensure accurate information in the cath lab.
MAT-2313415 v1.0
Indications: The PressureWire™ X Guidewire is indicated to direct a catheter through a blood vessel and to measure physiological parameters in the heart and in the coronary and peripheral blood vessels. Physiological parameters include blood pressure. The PressureWire™ X Guidewire can also measure blood temperature.
Contraindications: This guidewire is contraindicated for use in the cerebral vasculature.
Warnings:
Precautions:
Potential Adverse Events: Potential complications which may be encountered during all catheterization procedures include, but are not limited to: vessel dissection or occlusion, perforation, embolus, spasm, local and/or systemic infection, pneumothorax, congestive heart failure, myocardial infarction, hypotension, chest pain, renal insufficiency, serious arrhythmias, or death.
In addition, this device has a coating containing Polyethylene Glycol (PEG); potential allergic reactions (anaphylaxis) may occur during the interventional procedure if the patient is allergic to PEG.
MAT-2103599 v2.0
Stay Connected